Dr yaron werber biography
Dr yaron werber biography
Dr yaron werber biography husband!
Dr. Yaron Werber, Chief Business and Financial Officer, to Return to Wall Street
Dr. Werber will join Cowen and Company as Managing Director and Senior Biotechnology Analyst
effective September 24, 2018
Ovid has initiated a search to select a new CFO
NEW YORK, Sept.
Dr yaron werber biography wikipedia
04, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that Yaron Werber, M.D., chief business and financial officer, will leave the company effective Friday, September 21, 2018.
Dr. Werber joined Ovid as chief financial officer in June 2015 after nearly 15 years of experience as a highly-ranked biotechnology research analyst at marquee Wall Street firms. Dr. Werber will return to Wall Street as managing director and senior biotechnology analyst at Cowen and Company.
Members of management and the company's existing finance team, including Tim Daly, Ovid’s sen